Essential elements in depression and anxiety. Part i

Pharmacological Reports

Volumn 66, Issue 4, 2014, Pages 534-544

  Młyniec, Katarzyna ^a,b   Davies, Claire Linzi ^c   De Agüero Sánchez, Irene Gómez ^d   Pytka, Karolina ^a   Budziszewska, Bogusława ^a,b   Nowak, Gabriel ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d University of Madrid   (Spain)

Author keywords

Depression; Lithium; Magnesium; Trace elements; Zinc

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; CALCIUM; CHROMIUM; CHROMIUM CHLORIDE; CHROMIUM PICOLINATE; CYCLOSERINE; DESIPRAMINE; DEXTRO SERINE; DIAZEPAM; DILTIAZEM; DIZOCILPINE; FLUNARIZINE; IMIPRAMINE; LITHIUM CARBONATE; LITHIUM SALT; MAGNESIUM; MAGNESIUM CHLORIDE; MAGNESIUM GLYCINATE; MAGNESIUM HYDROASPARTATE; MAGNESIUM TAURINATE; MIFEPRISTONE; MONOAMINE OXIDASE INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RITANSERIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; ZINC; ANTIDEPRESSANT AGENT; IRON; LITHIUM; TRACE ELEMENT;

ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; ATAXIA; BIPOLAR DISORDER; CALCIUM CELL LEVEL; CALCIUM METABOLISM; CLINICAL EFFECTIVENESS; DEPRESSION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DIZZINESS; DRUG POTENTIATION; ELEVATED PLUS MAZE TEST; FORCED SWIM TEST; HUMAN; IRON DEFICIENCY; LITHIUM BLOOD LEVEL; LOW DRUG DOSE; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEFICIENCY; MAJOR DEPRESSION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; TRANQUILIZING ACTIVITY; TREMOR; UNSPECIFIED SIDE EFFECT; ZINC BLOOD LEVEL; ZINC DEFICIENCY; ANIMAL; ANXIETY; COMPLICATION; DEFICIENCY; METABOLISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; CALCIUM; DEPRESSION; HUMANS; IRON; LITHIUM; MAGNESIUM DEFICIENCY; TRACE ELEMENTS; ZINC;

EID: 84902468722     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2014.03.001     Document Type: Review

References (143)

1. B. Momčilović, J. Prejac, S. Brundić, S. Morović, A.V. Skalny, and N. Mimica et al. An essay on human and elements, multielement profiles, and depression Transl Neurosci 1 4 2010 322 334
2. K. Młyniec, C.L. Davies, B. Budziszewska, W. Opoka, W. Reczyński, and M. Sowa-Kućma et al. Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test Pharmacol Rep 64 3 2012 567 575
3. N. Singewald, C. Sinner, A. Hetzenauer, S.B. Sartori, and H. Murck Magnesium-deficient diet alters depression- and anxiety-related behavior in mice - influence of desipramine and Hypericum perforatum extract Neuropharmacology 47 8 2004 1189 1197 (Pubitemid 39572710)
4. M. Maes, P.C. D'Haese, S. Scharpé, P. D'Hondt, P. Cosyns, and M.E. De Broe Hypozincemia in depression J Affect Disord 31 2 1994 135 140 (Pubitemid 24183901)
5. R. Noyes, G.M. Dempsey, A. Blum, and G.L. Cavanaugh Lithium treatment of depression Compr Psychiatry 15 3 1974 187 193
6. G.A. Eby, and K.L. Eby Rapid recovery from major depression using magnesium treatment Med Hypotheses 67 2 2006 362 370 (Pubitemid 43825609)
7. G. Nowak, B. Szewczyk, J.M. Wieronska, P. Branski, A. Palucha, and A. Pilc et al. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats Brain Res Bull 61 2 2003 159 164 (Pubitemid 36794273)
8. C.J. Frederickson, S.W. Suh, D. Silva, C.J. Frederickson, and R.B. Thompson Zinc and health: current status and future directions importance of zinc in the central nervous system: the zinc-containing neuron J Nutr 130 5S Suppl 2000 1471 1483
9. K. Tóth Zinc in neurotransmission Annu Rev Nutr 31 2011 139 153
10. E. Poleszak, P. Wlaź, A. Wróbel, M. Dybała, M. Sowa, and S. Fidecka et al. Activation of the NMDA/glutamate receptor complex antagonizes the NMDA antagonist-induced antidepressant-like effects in the forced swim test Pharmacol Rep 59 5 2007 595 600
11. A. Piotrowska, A. Siwek, M. Wolak, B. Pochwat, B. Szewczyk, and W. Opoka et al. Involvement of the monoaminergic system in the antidepressant-like activity of chromium chloride in the forced swim test J Physiol Pharmacol 64 4 2013 493 498
12. F.N. Jacka, J.A. Pasco, A. Mykletun, L.J. Williams, A.M. Hodge, and S.L. O'Reilly et al. Association of Western and traditional diets with depression and anxiety in women Am J Psychiatry 167 3 2010 305 311
13. X. Yu, T. Ren, and X. Yu Disruption of calmodulin-dependent protein kinase II α/brain-derived neurotrophic factor (α-CaMKII/BDNF) signalling is associated with zinc deficiency-induced impairments in cognitive and synaptic plasticity Br J Nutr 110 12 2013 2194 2200
14. S.V. Waikar, and M.G. Craske Cognitive correlates of anxious and depressive symptomatology: an examination of the Helplessness/Hopelessness model J Anxiety Disord 11 1 1997 1 16 (Pubitemid 27199169)
15. B.P. Yochim, A.E. Mueller, and D.L. Segal Late life anxiety is associated with decreased memory and executive functioning in community dwelling older adults J Anxiety Disord 27 6 2013 567 575
16. I. Slutsky, N. Abumaria, L.-J. Wu, C. Huang, L. Zhang, and B. Li et al. Enhancement of learning and memory by elevating brain magnesium Neuron 65 2 2010 165 177
17. M. Siwek, D. Dudek, I.a Paul, M. Sowa-Kućma, A. Zieba, and P. Popik et al. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study J Affect Disord 118 1-3 2009 187 195
18. S.E. Lakhan, and K.F. Vieira Nutritional therapies for mental disorders Nutr J 2008 72
19. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch Int Pharmacodyn Thérapie 229 2 1977 327 336 (Pubitemid 8225714)
20. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Behavioural despair in rats: a new model sensitive to antidepressant treatments Eur J Pharmacol 47 4 1978 379 391
21. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology (Berl) 85 3 1985 367 370 (Pubitemid 15123115)
22. A.D. Sherman, G.L. Allers, F. Petty, and F.A. Henn A neuropharmacologically-relevant animal model of depression Neuropharmacology 18 11 1979 891 893 (Pubitemid 10188996)
23. R.C. Drugan, A.S. Basile, J.H. Ha, D. Healy, and R.J. Ferland Analysis of the importance of controllable versus uncontrollable stress on subsequent behavioral and physiological functioning Brain Res Brain Res Protoc 2 1 1997 69 74 (Pubitemid 28277495)
24. P. Willner, A. Towell, D. Sampson, S. Sophokleous, and R. Muscat Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant Psychopharmacology (Berl) 93 3 1987 358 364 (Pubitemid 17160661)
25. P. Willner, and P.J. Mitchell The validity of animal models of predisposition to depression Behav Pharmacol 13 3 2002 169 188 (Pubitemid 34816463)
26. K.D. Cairncross, B. Cox, R. Kerwin, C. Forster, and A.F. Wren Behavioural changes induced by olfactory bulb ablation and intrabulbar injection of 5,6-DHT: susceptibility to psychotropic drugs [proceedings] Br J Pharmacol 62 3 1978 400P 401P (Pubitemid 8293057)
27. J.P. Kelly, A.S. Wrynn, and B.E. Leonard The olfactory bulbectomized rat as a model of depression: an update Pharmacol Ther 74 3 1997 299 316 (Pubitemid 27425352)
28. M. Kubera, K. Curzytek, W. Duda, M. Leskiewicz, A. Basta-Kaim, and B. Budziszewska et al. A new animal model of (chronic) depression induced by repeated and intermittent lipopolysaccharide administration for 4 months Brain Behav Immun 2013 96 104
29. D. Schijven, V.C. Sousa, J. Roelofs, B. Olivier, and J.D.A. Olivier Serotonin 1A receptors and sexual behavior in a genetic model of depression Pharmacol Biochem Behav 2013 pii: S0091-3057(13):00346-8
30. Y. Zhao, R. Ma, J. Shen, H. Su, D. Xing, and L. Du A mouse model of depression induced by repeated corticosterone injections Eur J Pharmacol 581 1-2 2008 113 120
31. A. Skórzewska, M. Lehner, A. Wisłowska-Stanek, P. Krza̧ścik, A. Ziemba, and A. Płaźnik The effect of chronic administration of corticosterone on anxiety- and depression-like behavior and the expression of GABA-A receptor alpha-2 subunits in brain structures of low- and high-anxiety rats Horm Behav 65 1 2014 6 13
32. S.L. Sensi, P. Paoletti, A.I. Bush, and I. Sekler Zinc in the physiology and pathology of the CNS Nat Rev Neurosci 10 11 2009 780 791
33. Institute of Medicine, Food and Nutrition Board Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc 2001 National Academy Press Washington, DC 1 28
34. M. Maes, E. Vandoolaeghe, H. Neels, P. Demedts, A. Wauters, and H.Y. Meltzer et al. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness Biol Psychiatry 42 5 1997 349 358 (Pubitemid 27380969)
35. I.J. McLoughlin, and J.S. Hodge Zinc in depressive disorder Acta Psychiatr Scand 82 6 1990 451 453
36. M. Siwek, B. Szewczyk, D. Dudek, K. Styczeń, M. Sowa-Kućma, and K. Młyniec et al. Zinc as a marker of affective disorders Pharmacol Rep 65 6 2013 1512 1518
37. K. Młyniec, B. Budziszewska, W. Reczyński, U. Doboszewska, A. Pilc, and G. Nowak Zinc deficiency alters responsiveness to antidepressant drugs in mice Pharmacol Rep 65 3 2013 579 592
38. H. Tamano, F. Kan, M. Kawamura, N. Oku, and A. Takeda Behavior in the forced swim test and neurochemical changes in the hippocampus in young rats after 2-week zinc deprivation Neurochem Int 55 7 2009 536 541
39. N.M. Tassabehji, R.S. Corniola, A. Alshingiti, and C.W. Levenson Zinc deficiency induces depression-like symptoms in adult rats Physiol Behav 95 3 2008 365 369
40. M. Watanabe, H. Tamano, T. Kikuchi, and A. Takeda Susceptibility to stress in young rats after 2-week zinc deprivation Neurochem Int 56 3 2010 410 416
41. N. Whittle, G. Lubec, and N. Singewald Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice Amino Acids 36 1 2009 147 158
42. K. Młyniec, and G. Nowak Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants Pharmacol Rep 64 2 2012 249 255
43. B. Kroczka, A. Zieba, D. Dudek, A. Pilc, and G. Nowak Zinc exhibits an antidepressant-like effect in the forced swimming test in mice Pol J Pharmacol 52 5 2000 403 406
44. B. Kroczka, P. Branski, Palucha a, Pilc a, and G. Nowak Antidepressant-like properties of zinc in rodent forced swim test Brain Res Bull 55 2 2001 297 300 (Pubitemid 32722173)
45. B. Szewczyk, P. Brański, J.M. Wierońska, A. Paucha, A. Pilc, and G. Nowak Interaction of zinc with antidepressants in the forced swimming test in mice Pol J Pharmacol 54 6 2002 681 685 (Pubitemid 36124519)
46. A.O. Rosa, J. Lin, J.B. Calixto, A.R.S. Santos, and A.L.S. Rodrigues Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice Behav Brain Res 144 1-2 2003 87 93 (Pubitemid 37011169)
47. M.P. Cunha, D.G. Machado, L.E.B. Bettio, J.C. Capra, and A.L.S. Rodrigues Interaction of zinc with antidepressants in the tail suspension test Prog Neuropsychopharmacol Biol Psychiatry 32 8 2008 1913 1920
48. M. Sowa-Kućma, B. Legutko, B. Szewczyk, K. Novak, P. Znojek, and E. Poleszak et al. Antidepressant-like activity of zinc: further behavioral and molecular evidence J Neural Transm 115 12 2008 1621 1628
49. K. Cieślik, B. Klenk-Majewska, Z. Danilczuk, A. Wróbel, T. Łupina, and G. Ossowska Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats Pharmacol Rep 59 1 2007 46 52 (Pubitemid 46522701)
50. B. Szewczyk, E. Poleszak, P. Wlaź, A. Wróbel, E. Blicharska, and A. Cichy et al. The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test Prog Neuropsychopharmacol Biol Psychiatry 33 2 2009 323 329
51. J. Samardzić, K. Savić, N. Stefanović, R. Matunović, D. Baltezarević, and M. Obradović et al. Anxiolytic and antidepressant effect of zinc on rats and its impact on general behavioural parameters Vojnosanit Pregl 70 4 2013 391 395
52. G. Nowak, B. Szewczyk, and A. Pilc Zinc and depression. An update Pharmacol Rep 57 6 2005 713 718
53. A. Takeda, H. Tamano, T. Ogawa, S. Takada, M. Ando, and N. Oku et al. Significance of serum glucocorticoid and chelatable zinc in depression and cognition in zinc deficiency Behav Brain Res 226 1 2012 259 264
54. P. Skolnick, R.T. Layer, P. Popik, G. Nowak, I.A. Paul, and R. Trullas Adaptation of N-methyl-d-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression Pharmacopsychiatry 29 1 1996 23 26 (Pubitemid 26072654)
55. A. Pilc, J.M. Wierońska, and P. Skolnick Glutamate-based antidepressants: preclinical psychopharmacology Biol Psychiatry 73 12 2013 1125 1130
56. R. Trullas, and P. Skolnick Functional antagonists at the NMDA receptor complex exhibit antidepressant actions Eur J Pharmacol 185 1 1990 1 10 (Pubitemid 20254891)
57. P. Skolnick, P. Popik, and R. Trullas Glutamate-based antidepressants: 20 years on Trends Pharmacol Sci 30 11 2009 563 569
58. B. Szewczyk, E. Poleszak, M. Sowa-Kućma, A. Wróbel, S. Słotwiński, and J. Listos et al. The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test Amino Acids 39 1 2010 205 217
59. C.-H. Yang, C.-C. Huang, and K.-S. Hsu Behavioral stress enhances hippocampal CA1 long-term depression through the blockade of the glutamate uptake J Neurosci 25 17 2005 4288 4293 (Pubitemid 40628773)
60. B. Holst, K.L. Egerod, E. Schild, S.P. Vickers, S. Cheetham, and L.-O. Gerlach et al. GPR39 signaling is stimulated by zinc ions but not by obestatin Endocrinology 148 1 2007 13 20 (Pubitemid 46021433)
61. I. Depoortere GI functions of GPR39: novel biology Curr Opin Pharmacol 12 6 2012 647 652
62. K. Młyniec, B. Budziszewska, W. Reczyński, M. Sowa-Kućma, and G. Nowak The role of the GPR39 receptor in zinc deficient-animal model of depression Behav Brain Res 2013 23830 23835
63. K. Młyniec, and G. Nowak GPR39 up-regulation after selective antidepressants Neurochem Int 62 7 2013 936 939
64. K. Młyniec, U. Doboszewska, B. Szewczyk, M. Sowa-Kućma, P. Misztak, and W. Piekoszewski et al. The involvement of the GPR39-Zn(2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims Neuropharmacology 79 2014 290 297
65. A. Takeda, H. Tamano, F. Kan, H. Itoh, and N. Oku Anxiety-like behavior of young rats after 2-week zinc deprivation Behav Brain Res 177 1 2007 1 6 (Pubitemid 46054205)
66. A. Partyka, M. Jastrzȩbska-Wiȩsek, B. Szewczyk, K. Stachowicz, A. Sławińska, and E. Poleszak et al. Anxiolytic-like activity of zinc in rodent tests Pharmacol Rep 63 4 2011 1050 1055
67. M.S. Abdel-Maksoud, M. Abdel-hamid, and Y.M. Moustafa NMDA/glutamate mechanism of anxiolytic-like action of zinc in vogel conflict test in mice IOSR J Pharm 2 5 2012 04 12
68. M. Joshi, M. Akhtar, A.K. Najmi, A.H. Khuroo, and D. Goswami Effect of zinc in animal models of anxiety, depression and psychosis Hum Exp Toxicol 31 12 2012 1237 1243
69. R. Swaminathan Magnesium metabolism and its disorders Clin Biochem Rev 24 2 2003 47 66
70. J.E. Jones, R. Manalo, and E.B. Flink Magnesium requirements in adults Am J Clin Nutr 20 6 1967 632 635
71. E.S. Ford, and A.H. Mokdad Dietary magnesium intake in a national sample of US adults J Nutr 133 9 2003 2879 2880
72. R.J. Elin Magnesium metabolism in health and disease Dis Mon 34 4 1988 161 218
73. R. Iqbal, and A.H. Khan Possible causes of vitamin D deficiency (VDD) in Pakistani population residing in Pakistan J Pak Med Assoc 60 1 2010 1 2
74. N.E. Saris, E. Mervaala, H. Karppanen, J.A. Khawaja, and A. Lewenstam Magnesium. An update on physiological, clinical and analytical aspects Clin Chim Acta 294 1-2 2000 1 26 (Pubitemid 30155803)
75. W.E. Wacker, and A.F. Parisi Magnesium metabolism N Engl J Med 278 14 1968 772-6 concl
76. Z. Nahar, M.A.K. Azad, M.A. Rahman, M.A. Rahman, W. Bari, and S.N. Islam et al. Comparative analysis of serum manganese, zinc, calcium, copper and magnesium level in panic disorder patients Biol Trace Elem Res 133 3 2010 284 290
77. M.J. Millan The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review Eur J Pharmacol 500 1-3 2004 371 384 (Pubitemid 39304021)
78. S. Kawajiri, and R. Dingledine Multiple structural determinants of voltage-dependent magnesium block in recombinant NMDA receptors Neuropharmacology 32 11 1993 1203 1211 (Pubitemid 23322116)
79. M.L. Mayer, G.L. Westbrook, and P.B. Guthrie Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones Nature 309 5965 1984 261 263 (Pubitemid 14139936)
80. T. Yamakura, and K. Shimoji Subunit- and site-specific pharmacology of the NMDA receptor channel Prog Neurobiol 59 3 1999 279 298 (Pubitemid 29325000)
81. E. Poleszak, B. Szewczyk, A. Wlaź, S. Fidecka, P. Wlaź, and A. Pilc et al. D-Serine, a selective glycine/N-methyl-D-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice Pharmacol Rep 60 6 2008 996 1000
82. G.A. Eby, and K.L. Eby Magnesium for treatment-resistant depression: a review and hypothesis Med Hypotheses 74 4 2010 649 660
83. D. Frizel, A. Coppen, and V. Marks Plasma magnesium and calcium in depression Br J Psychiatry 115 529 1969 1375 1377
84. S.B. Sartori, N. Whittle, A. Hetzenauer, and N. Singewald Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment Neuropharmacology 62 1 2012 304 312
85. A. Muroyama, M. Inaka, H. Matsushima, H. Sugino, Y. Marunaka, and Y. Mitsumoto Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice Neurosci Res 63 1 2009 72 75
86. E. Poleszak, B. Szewczyk, E. Kedzierska, P. Wlaź, A. Pilc, and G. Nowak Antidepressant- and anxiolytic-like activity of magnesium in mice Pharmacol Biochem Behav 78 1 2004 7 12 (Pubitemid 38670508)
87. E. Poleszak, P. Wlaź, B. Szewczyk, E. Kedzierska, E. Wyska, and T. Librowski et al. Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: behavioral and pharmacokinetic studies in mice Pharmacol Biochem Behav 81 3 2005 524 529 (Pubitemid 40966798)
88. S. Decollogne, A. Tomas, C. Lecerf, E. Adamowicz, and M. Seman NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801 Pharmacol Biochem Behav 58 1 1997 261 268 (Pubitemid 27334381)
89. E. Poleszak, P. Wlaź, E. Kedzierska, M. Radziwon-Zaleska, A. Pilc, and S. Fidecka et al. Effects of acute and chronic treatment with magnesium in the forced swim test in rats Pharmacol Rep 57 5 2005 654 658
90. A.J. Giannini, A.M. Nakoneczie, S.M. Melemis, J. Ventresco, and M. Condon Magnesium oxide augmentation of verapamil maintenance therapy in mania Psychiatry Res 93 1 2000 83 87 (Pubitemid 30123138)
91. C. Aron, P. Simon, C. Larousse, and J.R. Boissier Evaluation of a rapid technique for detecting minor tranquilizers Neuropharmacology 10 4 1971 459 469
92. J.R. Boissier, P. Simon, and C. Aron A new method for rapid screening of minor tranquillizers in mice Eur J Pharmacol 4 2 1968 145 151
93. S. Pellow, and S.E. File Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat Pharmacol Biochem Behav 24 3 1986 525 529 (Pubitemid 16145187)
94. M.C. Jardim, R.L. Nogueira, F.G. Graeff, and R.L. Nunes-de-Souza Evaluation of the elevated T-maze as an animal model of anxiety in the mouse Brain Res Bull 48 4 1999 407 411 (Pubitemid 29234856)
95. J.R. Vogel, B. Beer, and D.E. Clody A simple and reliable conflict procedure for testing anti-anxiety agents Psychopharmacologia 21 1 1971 1 7
96. M. Bourin, and M. Hascoët The mouse light/dark box test Eur J Pharmacol 463 1-3 2003 55 65 (Pubitemid 36205072)
97. S.M. Miller, C.C. Piasecki, and J.S. Lonstein Use of the light-dark box to compare the anxiety-related behavior of virgin and postpartum female rats Pharmacol Biochem Behav 100 1 2011 130 137
98. M. Davis Fear-potentiated startle in rats Curr Protoc Neurosci 2001 Chapter 8Unit 8.11A
99. J. Brodkin, C. Busse, S.J. Sukoff, and M.A. Varney Anxiolytic-like activity of the mGluR5 antagonist MPEP: a comparison with diazepam and buspirone Pharmacol Biochem Behav 73 2 2002 359 366 (Pubitemid 34773437)
100. M. Razafsha, H. Behforuzi, H. Harati, R. Al Wafai, A. Khaku, and S. Mondello et al. An updated overview of animal models in neuropsychiatry Neuroscience 240 2013 204 218
101. R.G. Phillips, and J.E. LeDoux Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning Behav Neurosci 106 2 1992 274 285
102. G.N. Schrauzer Lithium: occurrence, dietary intakes, nutritional essentiality J Am Coll Nutr 21 1 2002 14 21 (Pubitemid 34123704)
103. T. Pascual, and J.L. Gonzalez A protective effect of lithium on rat behaviour altered by ibotenic acid lesions of the basal forebrain cholinergic system Brain Res 695 2 1995 289 292
104. N. Riadh, M.S. Allagui, E. Bourogaa, C. Vincent, F. Croute, and A. Elfeki Neuroprotective and neurotrophic effects of long term lithium treatment in mouse brain Biometals 24 4 2011 747 757
105. R.H. Howland Lithium: underappreciated and underused? J Psychosoc Nurs Ment Health Serv 45 8 2007 13 17
106. M.E. Sansone, and D.K. Ziegler Lithium toxicity: a review of neurologic complications Clin Neuropharmacol 8 3 1985 242 248 (Pubitemid 15019419)
107. M.K. Nixon, M. Hascoet, M. Bourin, and M.C. Colombel Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system Psychopharmacology (Berl) 115 1-2 1994 59 64 (Pubitemid 24207762)
108. J.P. Redrobe, and M. Bourin Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate Psychopharmacology (Berl) 141 4 1999 370 377 (Pubitemid 29190005)
109. A. Shaldubina, G. Agam, and R.H. Belmaker The mechanism of lithium action: state of the art, ten years later Prog Neuropsychopharmacol Biol Psychiatry 25 4 2001 855 866 (Pubitemid 32374970)
110. F.K. Goodwin, D.L. Murphy, D.L. Dunner, and W.E. Bunney Lithium response in unipolar versus bipolar depression Am J Psychiatry 129 1 1972 44 47
111. M. Hascoet, M. Bourin, and S. Khimake Additive effect of lithium and clonidine with 5-HT1A agonists in the forced swimming test Prog Neuropsychopharmacol Biol Psychiatry 18 2 1994 381 396
112. N.A. Crossley, and M. Bauer Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials J Clin Psychiatry 68 6 2007 935 940 (Pubitemid 47015495)
113. M. Bauer, and S. Dopfmer Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies J Clin Psychopharmacol 19 5 1999 427 434 (Pubitemid 29451507)
114. M. Bloch, Y. Schwartzman, O. Bonne, and B. Lerer Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind. Placebo-controlled study J Clin Psychopharmacol 17 1 1997 44 48 (Pubitemid 27047261)
115. P. Dusek, J. Jankovic, and W. Le Iron dysregulation in movement disorders Neurobiol Dis 46 1 2012 1 18
116. A.C. Snyder, L.L. Dvorak, and J.B. Roepke Influence of dietary iron source on measures of iron status among female runners Med Sci Sports Exerc 21 1 1989 7 10 (Pubitemid 19062840)
117. J.R. Hunt Bioavailability of iron, zinc, and other trace minerals from vegetarian diets Am J Clin Nutr 78 3 Suppl. 2003 633S 639S (Pubitemid 40012558)
118. S.R. Jaffrey, N.A. Cohen, T.A. Rouault, R.D. Klausner, and S.H. Snyder The iron-responsive element binding protein: a target for synaptic actions of nitric oxide Proc Natl Acad Sci USA 91 26 1994 12994 12998
119. J.H. Cheah, S.F. Kim, L.D. Hester, K.W. Clancy, S.E. Patterson, and V. Papadopoulos et al. NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1 Neuron 51 4 2006 431 440 (Pubitemid 44209322)
120. S. Yu, Y. Feng, Z. Shen, and M. Li Diet supplementation with iron augments brain oxidative stress status in a rat model of psychological stress Nutrition 27 10 2011 1048 1052
121. B. Lozoff, E. Jimenez, J. Hagen, E. Mollen, and A.W. Wolf Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy Pediatrics 105 4 2000 E51
122. J.L. Beard, M.K. Hendricks, E.M. Perez, L.E. Murray-Kolb, A. Berg, and L. Vernon-Feagans et al. Maternal iron deficiency anemia affects postpartum emotions and cognition J Nutr 135 2 2005 267 272 (Pubitemid 40194489)
123. J.R. Hunt, and J.G. Penland Iron status and depression in premenopausal women: an MMPI study. Minnesota Multiphasic Personality Inventory Behav Med 25 2 1999 62 68 (Pubitemid 29309743)
124. A.M. Konijn, and C. Hershko Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release Br J Haematol 37 1 1977 7 16 (Pubitemid 8210500)
125. T.-L. Huang, and C.-T. Lee Low serum albumin and high ferritin levels in chronic hemodialysis patients with major depression Psychiatry Res 152 2-3 2007 277 280 (Pubitemid 47212481)
126. R.T. Joffe, J. Levitt a, and L.T. Young The thyroid, magnesium and calcium in major depression Biol Psychiatry 40 5 1996 428 429 (Pubitemid 26301078)
127. S. Yamawaki, A. Kagaya, Y. Tawara, and M. Inagaki Intracellular calcium signaling systems in the pathophysiology of affective disorders Life Sci 62 17-18 1998 1665 1670 (Pubitemid 28210259)
128. C.L. Bowden, L.G. Huang, M.A. Javors, J.M. Johnson, E. Seleshi, and K. McIntyre et al. Calcium function in affective disorders and healthy controls Biol Psychiatry 23 4 1988 367 376 (Pubitemid 18043539)
129. S.L. Dubovsky, R.D. Franks, S. Allen, and J. Murphy Calcium antagonists in mania: a double-blind study of verapamil Psychiatry Res 18 4 1986 309 320 (Pubitemid 16071916)
130. N. Galeotti, A. Bartolini, and C. Ghelardini Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test Neuropharmacology 50 3 2006 309 316 (Pubitemid 43184359)
131. H.N.G. Krishna, K.B. Kumar, and K.S. Karanth Anxiolytic activity of calcium channel antagonists in experimental models of anxiety in rats Indian J pharmacol 33 2001 267 271 (Pubitemid 32842519)
132. R.A. Anderson, N.A. Bryden, and M.M. Polansky Dietary chromium intake. Freely chosen diets, institutional diet, and individual foods Biol Trace Elem Res 32 1992 117 121
133. H.A. Schroeder Diabetic-like serum glucose levels in chromium deficient rats Life Sci 4 21 1965 2057 2062
134. L.E. Egede Effects of depression on work loss and disability bed days in individuals with diabetes Diabetes Care 27 7 2004 1751 1753 (Pubitemid 38857457)
135. L.E. Egede, and C. Ellis Diabetes and depression: global perspectives Diabetes Res Clin Pract 87 3 2010 302 312
136. R. Khanam, and K.K. Pillai Effect of chromium picolinate on modified forced swimming test in diabetic rats: involvement of serotonergic pathways and potassium channels Basic Clin Pharmacol Toxicol 98 2 2006 155 159
137. M.J. Attenburrow, C. Williams, J. Odontiadis, J. Powell, F. Van de Ouderaa, and M. Williams et al. The effect of a nutritional source of tryptophan on dieting-induced changes in brain 5-HT function Psychol Med 33 8 2003 1381 1386 (Pubitemid 37483460)
138. M. Franklin, and J. Odontiadis Effects of treatment with chromium picolinate on peripheral amino acid availability and brain monoamine function in the rat Pharmacopsychiatry 36 5 2003 176 180 (Pubitemid 37357364)
139. A. Piotrowska, K. Młyniec, A. Siwek, M. Dybała, W. Opoka, and E. Poleszak et al. Antidepressant-like effect of chromium chloride in the mouse forced swim test: involvement of glutamatergic and serotonergic receptors Pharmacol Rep 60 6 2008 991 995
140. N. Iovieno, E.D. Dalton, M. Fava, and D. Mischoulon Second-tier natural antidepressants: review and critique J Affect Disord 130 3 2011 343 357
141. J.R.T. Davidson, K. Abraham, K.M. Connor, and M.N. McLeod Effectiveness of chromium in atypical depression: a placebo-controlled trial Biol Psychiatry 53 3 2003 261 264 (Pubitemid 36135938)
142. K.A. Brownley, S.S. Girdler, A.L. Stout, and M.N. McLeod Chromium supplementation for menstrual cycle-related mood symptoms J Diet Suppl 10 4 2013 345 356
143. M.N. McLeod, B.N. Gaynes, and R.N. Golden Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients J Clin Psychiatry 60 4 1999 237 240 (Pubitemid 29193921)